S&P Futures
5,424.50 +5.00 (+0.09%) Dow Futures
40,439.00 +32.00 (+0.08%) Nasdaq Futures
18,478.25 +20.00 (+0.11%) Russell 2000 Futures
2,094.40 -2.10 (-0.10%) Crude Oil
68.46 +0.79 (+1.17%) Gold
2,526.00 +1.40 (+0.06%)
10x Genomics, Inc. (TXG)
After hours:
| Previous Close | 23.14 |
| Open | 23.11 |
| Bid | 21.51 x 600 |
| Ask | 21.57 x 300 |
| Day's Range | 21.09 - 23.35 |
| 52 Week Range | 15.28 - 57.90 |
| Volume | |
| Avg. Volume | 1,836,764 |
| Market Cap | 2.595B |
| Beta (5Y Monthly) | 1.85 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.03 |
| Earnings Date | Oct 31, 2024 - Nov 04, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 27.43 |
PR Newswire10x Genomics Unveils Chromium Xo: A Low-Cost Instrument to Expand Access to High-Performance Single Cell Research
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of Chromium Xo, a new addition to its fleet of Chromium single cell instruments. Designed to meet the needs of researchers who desire high-quality data on limited budgets, Chromium Xo offers an affordable entry point into routine, high-performance single cell analysis.
- PR Newswire
10x Genomics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, at 10:45 a.m. Eastern Time.
GuruFocus.comCatherine Wood's Strategic Acquisition in 10x Genomics Inc.
On July 31, 2024, Catherine Wood (Trades, Portfolio)'s firm made a significant addition to its investment portfolio by acquiring 2,043,248 shares of 10x Genomics Inc. (NASDAQ:TXG). The shares were purchased at a price of $20.67, reflecting a strategic move to capitalize on the current market valuation of TXG. Catherine Wood (Trades, Portfolio), with over four decades of experience in investment management, founded ARK in 2014 with a focus on disruptive innovation.
